Docetaxel Phares

Docetaxel Phares is a pharmaceutical product containing anhydrous docetaxel, used for intravenous administration. It is a chemotherapy agent commonly prescribed for various types of cancer. This medication is manufactured by Pharma Resources GmbH and is available in the EU market.

Docetaxel Phares is primarily used in the treatment of various types of cancer, including breast, lung, prostate, and stomach cancers. It works by slowing or stopping the growth of cancer cells. The specific uses of docetaxel may vary depending on the type and stage of cancer, as determined by a healthcare provider.

Common effects of docetaxel may include fatigue, nausea, and hair loss. Some individuals may also experience changes in taste, fluid retention, or low blood cell counts. These effects can vary in severity and duration, and it is important to discuss any concerns with a healthcare professional.

Docetaxel Phares should be handled with care, as it is a potent medication. It is important to follow the administration guidelines provided by a healthcare professional. Pregnant women and individuals with certain medical conditions should exercise caution and consult a healthcare provider before use.

Docetaxel may interact with other medications, including those that affect the liver or bone marrow. It is important to inform a healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol consumption should be avoided during treatment.